title: Mesenteric vascular remodeling in hyperhomocysteinemia.
abstract: Remodeling by its very nature implies synthesis and degradation of extracellular matrix components (such as elastin, collagen, and connexins). Most of the vascular matrix metalloproteinase (MMP) are latent because of the presence of constitutive nitric oxide (NO). However, during oxidative stress peroxinitrite (ONOO-) activates the latent MMPs and instigates vascular remodeling. Interestingly, in mesenteric artery, homocysteine (Hcy) decreases the NO bio-availability, and folic acid (FA, an Hcy-lowering agent) mitigates the Hcy-mediated mesentery artery dysfunction. Dimethylarginine dimethylaminohydrolase-2 (DDAH-2) and endothelial nitric oxide synthase (eNOS) increases NO production. The hypothesis was that the Hcy decreased NO bio-availability, in part, activating MMP, decreasing elastin, DDAH-2, eNOS and increased vasomotor response by increasing connexin. To test this hypothesis,the authors used 12-week-old C57BJ/L6 wild type (WT) and hyperhomocysteinemic (HHcy)-cystathione beta synthase heterozygote knockout (CBS+/-) mice. Blood pressure measurements were made by radio-telemetry. WT and MMP-9 knockout mice were administered with Hcy (0.67 mg/ml in drinking water). Superior mesenteric artery and mesenteric arcade were analyzed with light and confocal microscopy. The protein expressions were measured by western blot analysis. The mRNA levels for MMP-9 were measured by RT-PCR. The data showed decreased DDAH-2 and eNOS expressions in mesentery in CBS-/+ mice compared with WT mice. Immuno-fluorescence and western blot results suggest increased MMP-9 and connexin-40 expression in mesenteric arcades of CBS-/+ mice compared with WT mice. The wall thickness of third-order mesenteric artery was increased in CBS-/+ mice compared to WT mice. Hcy treatment increased blood pressure in WT mice. Interestingly, in MMP-9 KO, Hcy did not increase blood pressure. These results may suggest that HHcy causes mesenteric artery remodeling and narrowing by activating MMP-9 and decreasing DDAH-2 and eNOS expressions, compromising the blood flow, instigating hypertension, and acute abdomen pain.
authors.affiliation: Department of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA.
authors.forename: C
authors.initials: C
authors.lastname: Munjal
authors.forename: S
authors.initials: S
authors.lastname: Givvimani
authors.forename: N
authors.initials: N
authors.lastname: Qipshidze
authors.forename: N
authors.initials: N
authors.lastname: Tyagi
authors.forename: J C
authors.initials: JC
authors.lastname: Falcone
authors.forename: S C
authors.initials: SC
authors.lastname: Tyagi
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D000581:Amidohydrolases / Q000378:metabolism; D000818:Animals; D001794:Blood Pressure; D018660:Blood Pressure Monitoring, Ambulatory; D015153:Blotting, Western; D017630:Connexins / Q000378:metabolism; D003541:Cystathionine beta-Synthase / Q000235:genetics / Q000378:metabolism; D004195:Disease Models, Animal; D004548:Elasticity; D004549:Elastin / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D006710:Homocysteine; D020138:Hyperhomocysteinemia / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D006973:Hypertension / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000172:deficiency / Q000235:genetics; D017538:Mesenteric Artery, Superior / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018613:Microscopy, Confocal; D018715:Microscopy, Video; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013152:Splanchnic Circulation; D013686:Telemetry; D014655:Vascular Resistance; D000097003:Gap Junction alpha-5 Protein
chemical_list: D000581:Amidohydrolases; D017630:Connexins; D003541:Cystathionine beta-Synthase; D004549:Elastin; D016326:Extracellular Matrix Proteins; D006710:Homocysteine; D020780:Matrix Metalloproteinase 9; D052250:Nitric Oxide Synthase Type III; D009573:Nitrites; D012333:RNA, Messenger; D000097003:Gap Junction alpha-5 Protein; C496315:Nos3 protein, mouse; C501830:Mmp9 protein, mouse; C059999:dimethylargininase